Open Access

A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes

  • Authors:
    • Chenggong Hu
    • Yongfang Zhou
    • Chang Liu
    • Yan Kang
  • View Affiliations

  • Published online on: June 6, 2018     https://doi.org/10.3892/ijo.2018.4433
  • Pages: 633-643
  • Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-associated mortality worldwide. In the current study, comprehensive bioinformatic analyses were performed to develop a novel scoring system for GC risk assessment based on CAP-Gly domain containing linker protein family member 4 (CLIP4) DNA methylation status. Two GC datasets with methylation sequencing information and mRNA expression profiling were downloaded from the The Cancer Genome Atlas and Gene Expression Omnibus databases. Differentially expressed genes (DEGs) between the CLIP4 hypermethylation and CLIP4 hypomethylation groups were screened using the limma package in R 3.3.1, and survival analysis of these DEGs was performed using the survival package. A risk scoring system was established via regression factor-weighted gene expression based on linear combination to screen the most important genes associated with CLIP4 methylation and prognosis. Genes associated with high/low-risk value were selected using the limma package. Functional enrichment analysis of the top 500 DEGs that positively and negatively associated with risk values was performed using DAVID 6.8 online and the gene set enrichment analysis (GSEA) software. In total, 35 genes were identified to be that significantly associated with prognosis and CLIP4 DNA methylation, and three prognostic signature genes, claudin-11 (CLDN11), apolipoprotein D (APOD), and chordin like 1 (CHRDL1), were used to establish a risk assessment system. The prognostic scoring system exhibited efficiency in classifying patients with different prognoses, where the low-risk groups had significantly longer overall survival times than those in the high-risk groups. CLDN11, APOD and CHRDL1 exhibited reduced expression in the hypermethylation and low-risk groups compare with the hypomethylation and high-risk groups, respectively. Multivariate Cox analysis indicated that risk value could be used as an independent prognostic factor. In functional analysis, six functional gene ontology terms and five GSEA pathways were associated with CLDN11, APOD and CHRDL1. The results established the credibility of the scoring system in this study. Additionally, these three genes, which were significantly associated with CLIP4 DNA methylation and GC risk assessment, were identified as potential prognostic biomarkers.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 53 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hu C, Zhou Y, Liu C and Kang Y: A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes. Int J Oncol 53: 633-643, 2018.
APA
Hu, C., Zhou, Y., Liu, C., & Kang, Y. (2018). A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes. International Journal of Oncology, 53, 633-643. https://doi.org/10.3892/ijo.2018.4433
MLA
Hu, C., Zhou, Y., Liu, C., Kang, Y."A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes". International Journal of Oncology 53.2 (2018): 633-643.
Chicago
Hu, C., Zhou, Y., Liu, C., Kang, Y."A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes". International Journal of Oncology 53, no. 2 (2018): 633-643. https://doi.org/10.3892/ijo.2018.4433